notificationsアラート設定
~
検索条件をクリア

アブストラクト

Title [合併症の予防と治療] 痛み, 不隠, せん妄の管理
Subtitle 特集 エキスパートが直伝! 敗血症の薬学的管理 最新版
Authors 毛利英之
Authors (kana)
Organization 金沢大学医薬保健研究域医学系麻酔・集中治療医学
Journal 月刊薬事
Volume 63
Number 9
Page 1807-1813
Year/Month 2021 / 7
Article 報告
Publisher じほう
Abstract [Points] ●敗血症に特異的な鎮痛薬・鎮静薬・せん妄治療薬は存在しない. ●鎮痛薬投与後に, 必要であれば鎮静薬を投与する. ●敗血症患者の鎮静薬はプロポフォールまたはデクスメデトミジンを用いる. ●敗血症患者のせん妄の予防・治療において, 質の高いエビデンスのある薬剤はない. ●睡眠障害に対して, デクスメデトミジンは自然な睡眠を誘導する可能性はあるが, エビデンスは蓄積されていない.
Practice 薬学
Keywords
  • 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
download全文ダウンロード(1.11MB)

参考文献

  • 1) Devlin JW, et al : Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med, 46 : e825-e873, 2018
    pubmed
  • 2) 日本集中治療医学会J-PADガイドライン検討委員会 : 集中治療領域における痛み・不穏・せん妄管理の現状調査. 日本集中治療医学会雑誌, 24 : 199-207, 2017
  • 3) Zhu Y, et al : Could remifentanil reduce duration of me-chanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis. Crit Care, 21 : 206, 2017
  • 4) 日本医薬情報センター : iyakuSearch 臨床試験情報 (https://www.clinicaltrials.jp/cti-user/trial/ShowDirect.jsp?clinicalTrialId=29802)
  • 5) Merelman AH, et al : Alternatives to rapid sequence intubation: Contemporary airway management with ketamine. West J Emerg Med, 20 : 466-471, 2019
    pubmed
残りの23件を表示する
  • 6) Manasco AT, et al : Ketamine sedation in mechanically ventilated patients: A systematic review and meta-analysis. J Crit Care, 56 : 80-88, 2020
    pubmed
  • 7) Garber PM, et al : Continuous infusion ketamine for adjunc-tive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy, 39 : 288-296, 2019
  • 8) 日本集中治療医学会J-PADガイドライン作成委員会 : 日本版・集中治療室における成人重症患者に対する痛み・不穏・せん妄管理のための臨床ガイドライン. 日本集中治療医学会雑誌, 21 : 539-579, 2014
  • 9) Rhodes A, et al : Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med, 43 : 304-377, 2017
    pubmed
  • 10) Venn RM, et al : Effects of dexmedetomidine on adreno-cortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth, 86 : 650-656, 2001
  • 11) Memis D, et al : Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth, 98 : 550-552, 2007
    pubmed
  • 12) Weerink MAS, et al : Clinical pharmacokinetics and pharmaco-dynamics of dexmedetomidine. Clin Pharmacokinet, 56 : 893-913, 2017
  • 13) Geloen A, et al : Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study. Crit Care Med, 41 : e431-438, 2013
    pubmed
  • 14) Lankadeva YR, et al : Clonidine restores pressor respon-siveness to phenylephrine and angiotensin II in ovine sepsis. Crit Care Med, 43 : e221-229, 2015
  • 15) Pichot C, et al : Increased pressor response to noradrenaline during septic shock following clonidine? Anaesth. Intensive Care, 38 : 784-785, 2010
    pubmed
  • 16) Morelli A, et al : The effect of propofol and dexmedetomidine sedation on norepinephrine requirements in septic shock patients: A crossover trial. Crit Care Med, 47 : e89-e95, 2019
    pubmed
  • 17) Kawazoe Y, et al : Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: A randomized clinical trial. JAMA, 317 : 1321-1328, 2017
    pubmed
  • 18) Chen P, et al : Effect of dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis. BMC Pulm Med, 20 : 42, 2020
    pubmed
  • 19) Shehabi Y, et al : Early sedation with dexmedetomidine in critically ill patients. N Engl J Med, 380 : 2506-2517, 2019
    pubmed
  • 20) Atterton B, et al : Sepsis associated delirium. Medicina(Kaunas), 56 : 240, 2020
    pubmed
  • 21) Ouimet S, et al : Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med, 33 : 1007-1013, 2007
    pubmed
  • 22) 厚生労働省 : 診療報酬の算定方法の一部改正に伴う実施上の留意事項について(令和2年3月5日保医発0305第1号)
  • 23) Barnes-Daly MA, et al : Improving hospital survival and reducing brain dysfunction at seven California community hospitals: Implementing PAD guidelines via the ABCDEF bundle in 6,064 patients. Crit Care Med, 45 : 171-178, 2017
    pubmed
  • 24) Reade MC, et al : Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: A randomized clinical trial. JAMA, 315 : 1460-1468, 2016
    pubmed
  • 25) Frontera JA : Delirium and sedation in the ICU. Neurocrit Care, 14 : 463-474, 2011
    pubmed
  • 26) Barr J, et al : Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med, 41 : 263-306, 2013
    pubmed
  • 27) Hatta K, et al : Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry, 71 : 397-403, 2014
    pubmed
  • 28) Nishikimi M, et al : Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: A single-center randomized placebo-controlled trial. Crit Care Med, 46 : 1099-1105, 2018
    pubmed
はじめての方へ
個人／法人会員登録のご案内